나성균
소화기병센터
전문과목
간질환, 간경변, 간암
진료시간
| 월 | 화 | 수 | 목 | 금 | 토 | |
|---|---|---|---|---|---|---|
| 오전 | ||||||
| 오후 |
- 바로가기 메뉴
- 본문 바로가기
- 주메뉴 바로가기
12월
-
- 날짜
- 2(월)
- 3(화)
- 1(수)
- 2(목)
- 3(금)
- 4(토)
-
- 오전
-
- 오후
-
- 날짜
- 6(월)
- 7(화)
- 8(수)
- 9(목)
- 10(금)
- 11(토)
-
- 오전
-
외래
-
- 오후
-
외래
-
- 날짜
- 13(월)
- 14(화)
- 15(수)
- 16(목)
- 17(금)
- 18(토)
-
- 오전
-
외래
-
외래
-
- 오후
-
외래
-
외래
-
- 날짜
- 20(월)
- 21(화)
- 22(수)
- 23(목)
- 24(금)
- 25(토)
-
- 오전
-
외래
-
- 오후
-
외래
-
- 날짜
- 27(월)
- 28(화)
- 29(수)
- 30(목)
- 31(금)
- 1(토)
-
- 오전
-
외래
-
외래
-
- 오후
-
외래
-
외래
- 학력/경력/주요활동
- 논문/저서
- 언론보도
학력사항
울산대학교 의학석사 (2015)
제주대학교 의학박사 (2023)
경력사항
서울아산병원 인턴 (2006)
한림대성심병원 전공의 (2011-2014)
고려대안산병원 임상강사 (2015)
서울아산병원 임상강사 (2016)
제주대학교병원 조교수 (2017-2022)
인제대학교 상계백병원 진료교수 (2023)
인제대학교 상계백병원 부교수 (2024-)
주요활동
대한간학회 교육위원 (2022-2023)
임상초음파학회 연구위원 (2023-)
대한간학회 학술위원 (2024-)
대한소화기학회 학술위원 (2024-)
아시아태평양 간학회 (APASL) Young investigator award (2017)
논문/저서
1. A Case of Successful Hepatic Resection after Insufficient Response to Transarterial Chemoembolization and Radiation Therapy in Hepatocellular Carcinoma with Portal Vein Invasion. Na SK, Yim HJ, Suh SJ, Jung YK. J. Liver Cancer 2016;16:118-122.
2. Histological expression of methionine adenosyl transferase (MAT) 2A as a post-surgical prognostic surrogate in patients with hepatocellular carcinoma. An J, Na SK, Shim JH et al. J Surg Oncol 2018;117:892-901
3. ALBI versus Child-Pugh grading systems for liver function in patients with hepatocellular carcinoma. Na SK, Yim SY, Suh SJ et al. J Surg Oncol 2018;117:912-921.
4. The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection. Na SK, Choi GH, Lee HC et al. PLoS ONE 13(6): e0198138. https://doi.org/10.1371/journal.pone.0198138
5. Prognostic assessment using a new substaging system for Barcelona clinic liver cancer stage C hepatocellular carcinoma: A nationwide study. Lee DW, Yim HJ, Seo YS, Na SK, et al. Liver Int 2019;39:1109-1119
6. Development and surveillance of hepatocellular carcinoma in patients with sustained virologic response after antiviral therapy for chronic hepatitis C. Na SK, Song BC. Clin Mol Hepatol 2019;25:234-244.
7. Aspartate Aminotransferase-to-Platelet Ratio or Fibros-4 Index Predicts the Development of Hepatocellular Carcinoma in Chronic Hepatitis C Patients with Sustained Virologic Response to Interferon Therapy. Na SK, Lee SJ, Cho YK, et al. J Interferon Cytokine Res 2019 Jun 19.[Epub ahead of print] 2019;39:703-710.
8. Fibrolamellar hepatocellular carcinoma that was successfully treated with surgical resection: a case report. Na SK. J Liver Cancer 2022;22:178-182.
9. Outcome of Intermittent Thoracentesis versus Pigtail Catheter Drainage for Hepatic Hydrothorax. Han SK, Kang SH, Kim MY, Na SK et al. J Clin Med 2022,11,7221. https://doi.org/10.3390/ jcm11237221.
10. The development of hepatocellular carcinoma during long-term treatment for recurrent non-small cell lung cancer: a case report. Na SK, Kang SH. J Liver Cancer 2023;23(1):230-234.
11. Etiology and clinical characteristics of acute viral hepatitis in South Korea during 2020-2021: a prospective multicenter study. Jeong CY, Choi GH, Jang ES, Kim YS, Lee YJ, Kim IH, Cho SB, Yoon JH, Kim KA, Choi DH, Chung WJ, Cho HC, Na SK, Kim YT, Lee BS, Jeong SH. Sci Rep. 2023 Aug 31;13(1):14271.
12. Prognosis Following Sustained Virologic Response in Korean Chronic Hepatitis C Patients Treated with Sofosbuvir-Based Treatment: Data from a Multicenter Prospective Observational Study up to 7 Years. Park Y, Na SK, Yoon JH, Kim SE, Park JW, Kim GA, Lee HY, Lee YS, Kim JH. Medicina (Kaunas). 2024 Jul 14;60(7):1132.
13. Validity of fatty liver prediction scores for diagnosis of fatty liver by Fibroscan. Jeong S, Park SJ, Na SK, Park SM, Song BC, Oh YH. Hepatobiliary Pancreat Dis Int. 2024 Aug;23(4):353-360.
14. LI-RADS for Diagnosing Hepatocellular Carcinoma in Patients with Noncirrhotic Chronic Hepatitis C. Radiology 2025; 314(3):e24185.